PATENT CLAIM ANALYSIS

Application Number: 15986033
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "430000"]

Abstract:
A composition for prevention or treatment of pulmonary fibrosis comprising chromenone derivatives represented by Formula I of the present invention or pharmaceutically acceptable salts thereof as an active ingredient, produces altered heat shock protein 27 (HSP27) dimers, thereby preventing normal HSP27 non-phosphorylated polymers from performing a chaperone function and reducing a cell protection function that chaperone originally performs. Thus the inventive composition has a remarkable inhibitory effect on pulmonary fibrosis, in particular, an irradiation-induced pulmonary fibrosis phenomenon.

Claim (Index 5):
The method of  claim 1 , wherein the pulmonary fibrosis is one or more selected from the group consisting of idiopathic pulmonary fibrosis, pulmonary fibrosis resulting from anticancer therapy, middle east respiratory syndrome (MERS) or pneumonia.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.26866
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13375217', '14317602', '14729969', '12309010', '13882363']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7356481810171721
- 35 USC 102 Novelty (BERT): 0.510655962693499
- Combined Prediction Score: 0.7131489591848048
- Mean Citation Score: 168.29004600000005
- Max Citation Score: 173.41737
- Similarity Product: 96.76127429329811

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test